Evidence map›Paper›PMID 41549134›Full record

ArticleVirchows Archiv : an international journal of pathology2026

POU2F3-positive neuroendocrine carcinoma of the urinary bladder showing basaloid morphology: expanding the morphologic spectrum of tuft cell-like carcinoma.

Ayaka Fukui, Naoki Nakajima, Yuki Teramoto, Shinsuke Shibuya, Yosuke Yamada, Kai Mizoguchi, Hironori Haga

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ayaka FukuiDepartment of Diagnostic Pathology, Uji-Tokushukai Medical Center, Kyoto, Japan.ORCID http://orcid.org/0009-0008-5117-9545
Naoki NakajimaDepartment of Diagnostic Pathology, Uji-Tokushukai Medical Center, Kyoto, Japan.
Yuki TeramotoDepartment of Diagnostic Pathology, Kyoto University Hospital, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. tera1980@kuhp.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-8620-0710
Shinsuke ShibuyaDepartment of Diagnostic Pathology, Kyoto Katsura Hospital, Kyoto, Japan.ORCID http://orcid.org/0000-0003-0604-9879
Yosuke YamadaDepartment of Molecular Pathology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7952-2706
Kai MizoguchiDepartment of Diagnostic Pathology, Kyoto University Hospital, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.ORCID http://orcid.org/0000-0001-9634-7209
Hironori HagaDepartment of Diagnostic Pathology, Kyoto University Hospital, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.ORCID http://orcid.org/0000-0003-4322-9561

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

POU2F3 defines tuft cell-like carcinomas, yet POU2F3-driven neuroendocrine neoplasia in the urinary bladder remains incompletely characterized and can morphologically mimic basaloid carcinomas. We report a case of an octogenarian woman with a diverticular bladder tumor composed of conventional high-grade urothelial carcinoma juxtaposed with a sharply demarcated basaloid component. Although the basaloid component lacked classical small-cell morphology and showed scant conventional neuroendocrine marker expression, it was diffusely POU2F3-positive, underscoring a potential diagnostic pitfall with human papillomavirus (HPV)-associated basaloid squamous cell carcinoma. Both components showed concordant aberrant tumor-suppressor immunoprofiles (p53 overexpression and Rb loss), and high-risk HPV RNA in situ hybridization (RNAscope) was negative. This case expands the recognized morphologic spectrum of bladder neuroendocrine carcinoma to include POU2F3-defined non-small cell neuroendocrine carcinoma with basaloid architecture, supporting the practical value of incorporating POU2F3 into immunohistochemical panels for poorly differentiated basaloid bladder tumors.

Indexed as

Bladder diverticulumNeuroendocrine tumorsPOU domain factorsTuft cellsUrinary bladder neoplasmsUrothelial carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.